-+ 0.00%
-+ 0.00%
-+ 0.00%

On August 4, Interface News noticed that the Pharmaceutical Representative Filing Platform showed that Li Mouze was included in illegal publicity because he carried out academic promotion and other activities without filing. This is the first case of pharmaceutical representative violation made public by the platform after the implementation of the new regulations on the management of pharmaceutical representatives. Earlier, on May 7 of this year, the State Drug Administration, together with seven departments including the Ministry of Public Security, the National Health Commission, the General Administration of Market Supervision, the National Health Insurance Administration, the State Administration of Traditional Chinese Medicine, and the National Administration for Disease Control and Prevention, jointly issued the “Administrative Measures on Pharmaceutical Representatives”. This measure is known by the industry as the “strictest in history” pharmaceutical representative new regulation, and it was officially implemented on August 1 this year.

智通財經·08/04/2026 08:17:10
語音播報
On August 4, Interface News noticed that the Pharmaceutical Representative Filing Platform showed that Li Mouze was included in illegal publicity because he carried out academic promotion and other activities without filing. This is the first case of pharmaceutical representative violation made public by the platform after the implementation of the new regulations on the management of pharmaceutical representatives. Earlier, on May 7 this year, the State Drug Administration, together with seven departments including the Ministry of Public Security, the National Health Commission, the General Administration of Market Supervision, the National Health Insurance Administration, the State Administration of Traditional Chinese Medicine, and the National Administration for Disease Control and Prevention, jointly issued the “Administrative Measures on Pharmaceutical Representatives”. This measure is known by the industry as the “strictest in history” pharmaceutical representative new regulation, and it was officially implemented on August 1 this year.